CAC2 Childhood Cancer Community News Digest (March 14-22)
Assorted news from the last week: This week the Honda Classic gold tournament served as the launching off point for the annual Play Yellow campaign
Assorted news from the last week: This week the Honda Classic gold tournament served as the launching off point for the annual Play Yellow campaign
Assorted news from the last two weeks: NCI commissioned the Agency for Healthcare Research and Quality (AHRQ) Technical Brief to support the development of a research
Assorted news from the last week: The National Comprehensive Cancer Network (NCCN) has issued guidelines for the management of children with Wilms Tumor, or nephroblastoma.
Assorted news from the last week: The U.S. Food and Drug Administration (FDA) has developed graphics that provide a visualization of recommendations about the use
Assorted news from the last week: In celebration of International Childhood Cancer Awareness Day on February 15, the World Health Organization released a suite of tools
Assorted news from the last week: The largest single cell study to date of the childhood cancer, neuroblastoma, has answered important questions about the genesis
Assorted news from the last week: Jared Isaacman, 37-year-old founder of Shift4 Payments, is chartering a SpaceX trip to orbit and raffling a seat to

By CAC2 Member Patti Gustafson, Swifty Foundation For years we looked to medical professionals to tell us what we needed to know to treat our
Assorted news from the last week: Sadly, as the 2020 Childhood Cancer Prevention Report confirms, childhood cancer incidence rates, the number of new cases per
Assorted news from the last two weeks: FDA approval of Pfizer’s XALKORI® (crizotinib) is a major milestone in the treatment of children and young adults